Abstract
Dependence and abuse of any substance can produce public health and social problems. Health authorities must be concerned with such problems and attempts to solve them often involve the use of legislation. Where the problem is local, legislation should equally be local. When there is a more general, international problem, then the question arises whether local legislation enacted by individual countries is adequate or whether a broader internationally based control system represents a more appropriate solution. The benzodiazepines are substances for which there is a dependence risk and some abuse. This is considered in Chapter 13. Hence it is important to examine their relationship to local and international legislation and the present chapter attempts this task.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Addiction Research Foundation: Report of the “International Working Group on the Convention on Psychotropic Substances, 1971”. Alcohol and Drug Addiction Research Foundation, Toronto, September 8-12, 1980.
Kramer JC: Social benefits and social costs of drug control laws.J Drug Issues 1978; 8: 1–7.
Lande A : Principles of effective drug abuse control. Papers presented at the International Institute on the Prevention and Treatment of Drug Dependence, 1970, pp 51–79.
Lind RC : Benefit-cost approach to evaluation of programs, inControlling Drugs: International Handbook for Psychoactive Drug Classification. United Nations Social Defence Research Institute, Rome. London, Jossey-Bass, 1974.
Soueif MI: The Psychotropic Convention in Egypt, in Smart R, Murray GF, Archibald HD (eds): Psychotropic Substances and Their International Control. Toronto, Alcohol and Drug Addiction Research Foundation, 1981.
United Nations: United Nations Convention on Psychotropic Substances 1971. New York, United Nations, 1971a.
United Nations: Commentary on the Convention on Psychotropic Substances 1971. New York, United Nations, 1971b.
United Nations: Psychoactive Drug Control: Issues and Recommendations. Rome, United Nations Social Defence Research Institute, 1973.
United Nations: Report of the Seventh Special Session of the Commission on Narcotic Drugs. Vienna, United Nations Organisation, 1982.
United Nations: Report of the Thirtieth Session of the Commission on Narcotic Drugs. Vienna, United Nations Organisation, 1983.
WHO: Expert Committee on Drug Dependence: Sixteenth Report, World Health Org Tech Rep Ser No 407. Geneva, WHO, 1969.
WHO: World Health Organisation Expert Committee on Drug Dependence: Twenty-first Report, Tech Rep Ser No 618. Geneva, WHO, 1978.
WHO: Assessment of Public Health and Social Problems Associated with the Use of Psychotropic Drugs: Report of the WHO Expert Committee on the Implementation of the Convention on Psychotropic Substances,1971, World Health Org Tech Rep Ser No 656. Geneva, WHO, 1981a.
WHO: Reportof the Fifth World Health Organisation Review of Psychoactive Substances for International Control. Geneva, WHO, November 16–20, 1981b.
WHO: Report of the Sixth World Health Organisation Review of Psychoactive Substances for International Control. Geneva, WHO, September 6–10, 1982.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1985 MTP Press Limited
About this chapter
Cite this chapter
Marks, J. (1985). Benzodiazepines: International Legislation and Relation to the Convention on Psychotropic Substances 1971. In: Smith, D.E., Wesson, D.R. (eds) The Benzodiazepines: Current Standards for Medical Practice. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-4886-0_20
Download citation
DOI: https://doi.org/10.1007/978-94-009-4886-0_20
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-8663-9
Online ISBN: 978-94-009-4886-0
eBook Packages: Springer Book Archive